Agilent Technologies, Inc.

Stocks

A

US00846U1016

Market Closed - NYSE Other stock markets 04:02:51 2026-07-20 pm EDT			Pre-market 06:24:18 am
130.26 ^USD	-0.91%		129.36	-0.69%

Jul. 20	HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited	CI
Jul. 14	Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma	CI

Transcript : Agilent Technologies, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09

Published on 06/03/2026 at 11:37 am EDT - Modified on 06/12/2026 at 02:06 pm EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Tycho Peterson (Analysts)

Okay. Great. We're going to kick it off. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce Agilent this morning.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Agilent Technologies, Inc.

Jul. 20	HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited	CI
Jul. 14	Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma	CI
Jul. 14	Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers	MT
Jul. 13	Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating	MT
Jul. 08	Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis	CI
Jul. 06	Evercore ISI Adjusts Agilent Technologies PT to $148 From $144	MT
Jul. 01	Agilent Technologies Launches Xcelligence RTCA Esight AI Module	CI
Jun. 26	Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron…
Jun. 25	Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032	CI
Jun. 25	Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP.	CI
Jun. 25	Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group	MT
Jun. 23	Barclays Adjusts Price Target on Agilent Technologies to $150 From $145, Maintains Overweight Rating	MT
Jun. 03	Trading Day: War clouds and tech wobbles	RE
Jun. 03	Agilent Technologies, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:20 AM
Jun. 03	Agilent Technologies Partners With OpenAI, Boston Consulting for AI Deployment	MT